Super Religare Laboratories Breaking News Tilt Biotherapeutics Mulls Biomarker Strategies as it Advances Oncolytic Viral Therapy Opdivo Perioperative Regimen Approved in Europe for PD-L1-Positive NSCLC Patients Pathos AI Raises $365M in Series D Financing to Advance AI Oncology Drug Development QurAlis Inks Deals to Advance Precision Medicine for Fragile X Syndrome In Brief This Week: Hemogenyx, Prevencio, Beam, Abeona, Sarepta, Cure Rare Disease OncoHost, Hospital Partners Nab €2.5M Grant for Cancer Treatment Biomarker Development
